Search results
Accelerated Biosciences and Spanios Partner to Advance Therapeutic Design Across Solid Tumor Cancers
FOX 59 Indianapolis· 10 hours agoSpanios, a firm that created and leverages its unique 3D tumoroid platforms to validate solid tumor therapies today announced a partnership with Accelerated Biosciences, a company that licenses ...
BrainStorm Cell Therapeutics Announces First Quarter 2024 Financial Results and Provides Corporate...
WKRN Nashville· 2 days agoBrainStorm Cell Therapeutics Inc. (NASDAQ: BCLI), a leading developer of adult stem cell therapeutics for neurodegenerative diseases, ...
Ozzy Osbourne's son Jack says rock star's 'blue-collar' work ethic led to smashing success
Fox News via Yahoo News· 6 days agoOzzy Osbourne's son, Jack Osbourne, explained how he learned the value of a strong work ethic from...
Compugen Publishes Paper in Cancer Immunology Research on Unique Biology of PVRIG and its...
FOX21 Colorado Springs· 8 hours ago(Nasdaq: CGEN) (TASE: CGEN) a clinical-stage cancer immunotherapy company and a pioneer in computational target discovery, today announced the online publication of a peer reviewed paper titled ...
Brookfield cancer patient gets ‘a second chance on life’ with stem cells from a Canadian athlete
The News-Times· 2 days agoSubmission of a sample to a national donor program sparked an unexpected connection between a...
Tooth regrowth drug set for human trials in Japan
The Register· 3 days agoJapanese researchers plan to begin human trials of a tooth regrowth drug this fall at Kyoto University Hospital following successful animal trials. A...
Fate Therapeutics Inc (FATE) Q1 2024 Earnings: Mixed Financial Performance Amid Clinical ...
GuruFocus.com via Yahoo Finance· 6 days agoThe company's focus extends across various NK- and T-cell immuno-oncology programs, aiming to revolutionize treatment modalities for patients with complex ...
Syndax Pharmaceuticals Appoints Aleksandra Rizo, M.D., Ph.D. to the Board of Directors
The Woonsocket Call· 23 hours agoSyndax Pharmaceuticals (Nasdaq: SNDX), a clinical-stage biopharmaceutical company developing an innovative pipeline of cancer therapies, today announced the appointment of Aleksandra Rizo, M.D ...
Q1 2024 Predictive Oncology Inc Earnings Call
Thomson Reuters StreetEvents via Yahoo Finance· 15 hours agoMoreover, as I mentioned in our last update, we have recently announced the development of our latest stem cell technology breakthrough, a novel protein ...
Syndax Pharmaceuticals, Inc. (NASDAQ:SNDX) Q1 2024 Earnings Call Transcript
Insider Monkey via Yahoo Finance· 4 days agoSyndax Pharmaceuticals, Inc. (NASDAQ:SNDX) Q1 2024 Earnings Call Transcript May 8, 2024 Syndax...
